# A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis

> **NCT07355062** · PHASE3 · RECRUITING · sponsor: **Renibus Therapeutics, Inc.** · enrollment: 150 (estimated)

## Conditions studied

- CKD
- Metabolic Acidosis

## Interventions

- **DRUG:** Veverimer
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07355062
- **Lead sponsor:** Renibus Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-13
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07355062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07355062, "A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07355062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*